About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Il4tm1Cgn
targeted mutation 1, University of Cologne
MGI:1857194
Summary 18 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Il4tm1Cgn/Il4tm1Cgn B6.129P2-Il4tm1Cgn/J MGI:4818944
hm2
Il4tm1Cgn/Il4tm1Cgn B6.Cg-Il4tm1Cgn MGI:3038309
hm3
Il4tm1Cgn/Il4tm1Cgn either: NOD.129-Il4tm1Cgn or (involves: 129 * NOD) MGI:3625060
hm4
Il4tm1Cgn/Il4tm1Cgn involves: 129P2/OlaHsd * A/WySn * C57BL/10SnSg * Swiss MGI:4843968
hm5
Il4tm1Cgn/Il4tm1Cgn involves: 129P2/OlaHsd * C57BL/6 MGI:3689881
hm6
Il4tm1Cgn/Il4tm1Cgn involves: 129P2/OlaHsd * C57BL/6J * MRL/Mp MGI:4839052
hm7
Il4tm1Cgn/Il4tm1Cgn involves: 129P2/OlaHsd * NOD MGI:3623295
hm8
Il4tm1Cgn/Il4tm1Cgn MRL.129P2-Il4tm1Cgn MGI:3799735
hm9
Il4tm1Cgn/Il4tm1Cgn NOD.129P2-Il4tm1Cgn MGI:3622411
hm10
Il4tm1Cgn/Il4tm1Cgn NOD.Cg-H2b Il4tm1Cgn MGI:3622418
cx11
Il21rtm1Wjl/Il21rtm1Wjl
Il4tm1Cgn/Il4tm1Cgn
involves: 129 * C57BL/6 MGI:3813932
cx12
Il4tm1Cgn/Il4tm1Cgn
Ndfip1Gt(RRD002)Byg/Ndfip1Gt(RRD002)Byg
involves: 129P2/OlaHsd MGI:5550267
cx13
Il4tm1Cgn/Il4tm1Cgn
Tg(CD2-Stat6*V625A*T626A)78Mhk/0
involves: 129P2/OlaHsd * C3H * C57BL/6 MGI:4818945
cx14
Il2tm1Hor/Il2tm1Hor
Il4tm1Cgn/Il4tm1Cgn
involves: 129P2/OlaHsd * C57BL/6 MGI:3759409
cx15
Il10tm1Cgn/Il10tm1Cgn
Il4tm1Cgn/Il4tm1Cgn
involves: 129P2/OlaHsd * C57BL/6 MGI:3851988
cx16
Faslpr/Faslpr
Il4tm1Cgn/Il4tm1Cgn
involves: 129P2/OlaHsd * C57BL/6J * MRL/Mp MGI:4839051
cx17
Faslpr/Faslpr
Il4tm1Cgn/Il4tm1Cgn
MRL.Cg-Il4tm1Cgn Faslpr MGI:3799736
cx18
Il4tm1Cgn/Il4tm1Cgn
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
NOD.Cg-Il4tm1Cgn Tg(TcraBDC2.5,TcrbBDC2.5)1Doi MGI:3625063


Genotype
MGI:4818944
hm1
Allelic
Composition
Il4tm1Cgn/Il4tm1Cgn
Genetic
Background
B6.129P2-Il4tm1Cgn/J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il4tm1Cgn mutation (4 available); any Il4 mutation (46 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
N
• survival time of cardiac allografts (BALB/c origin) is similar to wild-type mice, unlike in Ifng or Il10 null mice (J:44346)
• dendritic function is normal (J:160119)

integument
• despite normal dendritic function, mice whose backs are shaved and painted with Alexa 647-labeled ovalbumin accumulate fewer Alexa647+CD11c+ cells in draining lymph nodes compared with similarly treated wild-type mice indicating increased barrier function




Genotype
MGI:3038309
hm2
Allelic
Composition
Il4tm1Cgn/Il4tm1Cgn
Genetic
Background
B6.Cg-Il4tm1Cgn
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il4tm1Cgn mutation (4 available); any Il4 mutation (46 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• homozygotes display impaired pulmonary granuloma formation in response to schistosome egg immunization
• eosinophil infiltration is impaired in response to schistosome egg immunization
• IgG1 response to immunization with the protein antigen OVA is severely impaired

hematopoietic system
• homozygotes display impaired pulmonary granuloma formation in response to schistosome egg immunization
• eosinophil infiltration is impaired in response to schistosome egg immunization




Genotype
MGI:3625060
hm3
Allelic
Composition
Il4tm1Cgn/Il4tm1Cgn
Genetic
Background
either: NOD.129-Il4tm1Cgn or (involves: 129 * NOD)
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il4tm1Cgn mutation (4 available); any Il4 mutation (46 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• at 12 weeks, insulitis incidence is similar in homozygous mutants and heterozygous controls on the NOD background (N4)

immune system
• at 12 weeks, insulitis incidence is similar in homozygous mutants and heterozygous controls on the NOD background (N4)
• there is no difference in timing or penetrance of diabetes in IL4-deficient NOD mice (N8) compared to heterozygous or wild-type NOD mice

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
type 1 diabetes mellitus DOID:9744 OMIM:222100
J:85924




Genotype
MGI:4843968
hm4
Allelic
Composition
Il4tm1Cgn/Il4tm1Cgn
Genetic
Background
involves: 129P2/OlaHsd * A/WySn * C57BL/10SnSg * Swiss
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il4tm1Cgn mutation (4 available); any Il4 mutation (46 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
• abnormal IgG responses to HgCL2 exposure
• however, mercury induced increases in autoantibodies are similar to controls

immune system
• following exposure to HgCl2 for 4 weeks, relative to similarly treated wild-type and heterozygous mice
• following exposure to HgCl2 for 4 weeks, relative to similarly treated wild-type and heterozygous mice

hematopoietic system
• following exposure to HgCl2 for 4 weeks, relative to similarly treated wild-type and heterozygous mice
• following exposure to HgCl2 for 4 weeks, relative to similarly treated wild-type and heterozygous mice




Genotype
MGI:3689881
hm5
Allelic
Composition
Il4tm1Cgn/Il4tm1Cgn
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il4tm1Cgn mutation (4 available); any Il4 mutation (46 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• there were no dectectable levels of IgE in 5 of 6 mice compared to controls, which all had dectectable levels
• after infection with a nematode, 6-week old animals have almost undetectable IgE levels compared to controls which show about 50-fold increase in levels after infection
• homozygotes have about 1/6 the level of IgG1 of wild-type at 6 weeks
• in response to immunization with chicken globulin, antibodies produced by mutants are ~40-50% IgG1, while wild-type mice produce >95% IgG1-specific antibodies
• conA stimulated spleen cells from homozygotes secrete ~800-fold less Il4 than control cells
• upon infection with Schistosoma mansoni eggs, primary granuloma formation and volume is equivalent to wild-type
• volumes of secondary granulomas after second exposure with parasite eggs are reduced by ~50% compared to wild-type

hematopoietic system
• there were no dectectable levels of IgE in 5 of 6 mice compared to controls, which all had dectectable levels
• after infection with a nematode, 6-week old animals have almost undetectable IgE levels compared to controls which show about 50-fold increase in levels after infection
• homozygotes have about 1/6 the level of IgG1 of wild-type at 6 weeks
• in response to immunization with chicken globulin, antibodies produced by mutants are ~40-50% IgG1, while wild-type mice produce >95% IgG1-specific antibodies




Genotype
MGI:4839052
hm6
Allelic
Composition
Il4tm1Cgn/Il4tm1Cgn
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6J * MRL/Mp
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il4tm1Cgn mutation (4 available); any Il4 mutation (46 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• at 3 months of age relative to wild-type controls
• at 3 and 7-8 months of age relative to wild-type controls

hematopoietic system
• at 3 months of age relative to wild-type controls
• at 3 and 7-8 months of age relative to wild-type controls




Genotype
MGI:3623295
hm7
Allelic
Composition
Il4tm1Cgn/Il4tm1Cgn
Genetic
Background
involves: 129P2/OlaHsd * NOD
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il4tm1Cgn mutation (4 available); any Il4 mutation (46 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• CD4+ T cells from deficient animals show a reduction in circulating IgG1 in the absence of deliberate immunization
• CD4+ T cells from deficient animals show a strongly reduced ability to produce Il5 after anti-TCR stimulation compared to wild-type cells

hematopoietic system
• CD4+ T cells from deficient animals show a reduction in circulating IgG1 in the absence of deliberate immunization




Genotype
MGI:3799735
hm8
Allelic
Composition
Il4tm1Cgn/Il4tm1Cgn
Genetic
Background
MRL.129P2-Il4tm1Cgn
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il4tm1Cgn mutation (4 available); any Il4 mutation (46 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• dacryoadenitis, characterized by multiple foci of mononuclear inflammatory cells
• predominant cell type in infiltrate at various ages is CD4+ T cells (66%); CD8+ T cells make up 12% of infiltrate
• B cells are more abundant in infiltrates (30%) than in MRL.Cg- Il4tm1Cgn Faslpr mice

vision/eye
• dacryoadenitis, characterized by multiple foci of mononuclear inflammatory cells
• predominant cell type in infiltrate at various ages is CD4+ T cells (66%); CD8+ T cells make up 12% of infiltrate
• B cells are more abundant in infiltrates (30%) than in MRL.Cg- Il4tm1Cgn Faslpr mice

endocrine/exocrine glands
• dacryoadenitis, characterized by multiple foci of mononuclear inflammatory cells
• predominant cell type in infiltrate at various ages is CD4+ T cells (66%); CD8+ T cells make up 12% of infiltrate
• B cells are more abundant in infiltrates (30%) than in MRL.Cg- Il4tm1Cgn Faslpr mice




Genotype
MGI:3622411
hm9
Allelic
Composition
Il4tm1Cgn/Il4tm1Cgn
Genetic
Background
NOD.129P2-Il4tm1Cgn
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il4tm1Cgn mutation (4 available); any Il4 mutation (46 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
• mice are diabetic if 2 consecutive measures of blood glucose are >240 mg/dl
• amylase activity increases slightly between 4 and 20 weeks of age (234 to 291 U/L) compared to activity in wild-type which declines
• parotid secretory protein protease activity is retained in mutants while non-diseased BALB/c animals do not show activity

endocrine/exocrine glands
• mice do not exhibit a decrease in salivary flow rates compared to NOD.B10-H2b mice at 4 weeks of age
• saliva maintains normal protein concentrations compared to NOD and NOD.B10-H2b controls

immune system
• in null females challenged with coxsackievirus B4 at 8 weeks of age, diabetes onset is not accelerated as it is in wild-type NOD females; over the 25-week follow up period, only 23% of CVB4 exposed nulls develop diabetes compared to 63% of saline-treated controls
• at 12 weeks of age, null females challenged with CVB4 develop diabetes at an accelerated rate compared with saline-treated controls (80% at 10 days after infection versus 30% of controls)

digestive/alimentary system
• mice do not exhibit a decrease in salivary flow rates compared to NOD.B10-H2b mice at 4 weeks of age
• saliva maintains normal protein concentrations compared to NOD and NOD.B10-H2b controls

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
Sjogren's syndrome DOID:12894 OMIM:270150
J:105803




Genotype
MGI:3622418
hm10
Allelic
Composition
Il4tm1Cgn/Il4tm1Cgn
Genetic
Background
NOD.Cg-H2b Il4tm1Cgn
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il4tm1Cgn mutation (4 available); any Il4 mutation (46 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
• amylase activity increases slightly between 4 and 20 weeks of age(181 to 250 U/L) compared to activity in wild-type which decreases (386 to 288 U/L)
• parotid secretory protein protease activity is retained in mutants while non-diseased animals do not show activity

endocrine/exocrine glands
• mice do not exhibit a decrease in salivary flow rates compared to NOD.B10-H2b mice at 4 weeks of age; normal salivary flow is retained to 36 weeks of age compared to controls
• saliva maintains normal protein concentrations compared to NOD and NOD.B10-H2b controls
• foci of leukocytic infiltration contain more T cells than NOD.B10-H2b controls
• foci of leukocytic infiltration contain more T cells than NOD.B10-H2b controls

immune system
• foci of leukocytic infiltration contain more T cells than NOD.B10-H2b controls
• foci of leukocytic infiltration contain more T cells than NOD.B10-H2b controls

vision/eye
• foci of leukocytic infiltration contain more T cells than NOD.B10-H2b controls

digestive/alimentary system
• mice do not exhibit a decrease in salivary flow rates compared to NOD.B10-H2b mice at 4 weeks of age; normal salivary flow is retained to 36 weeks of age compared to controls
• saliva maintains normal protein concentrations compared to NOD and NOD.B10-H2b controls
• foci of leukocytic infiltration contain more T cells than NOD.B10-H2b controls

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
Sjogren's syndrome DOID:12894 OMIM:270150
J:105803




Genotype
MGI:3813932
cx11
Allelic
Composition
Il21rtm1Wjl/Il21rtm1Wjl
Il4tm1Cgn/Il4tm1Cgn
Genetic
Background
involves: 129 * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il21rtm1Wjl mutation (6 available); any Il21r mutation (42 available)
Il4tm1Cgn mutation (4 available); any Il4 mutation (46 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• serum levels of IgGA in nave mice are lower than in controls
• similar defects are noted upon immunization with keyhole limpet hemocyanin (KLH)
• serum levels of IgG1 in nave mice are several log units lower than in controls
• these mice have severely impaired production of antigen-specific IgG1 after immunization with trinitrophenyl-conjugated chicken gamma-globulin (TNP-CGG)
• similar defects are noted upon immunization with KLH
• serum levels of IgG2a in nave mice are lower than in controls
• these mice have severely impaired production of antigen-specific IgG2a after immunization with TNP-CGG
• similar defects are noted upon immunization with KLH
• serum levels of IgG2b in nave mice are lower than in controls
• these mice have severely impaired production of antigen-specific IgG2b after immunization with TNP-CGG
• similar defects are noted upon immunization with KLH
• serum levels of IgG3 in nave mice are lower than in controls
• these mice have severely impaired production of antigen-specific IgG3 after immunization with TNP-CGG
• similar defects are noted upon immunization with KLH
• these mice have 10 to 20% of normal production levels of antigen-specific IgG2b after immunization with TNP-CGG
• similar defects are noted upon immunization with KLH
• lymph nodes after immunization have barely recognizable, poorly organized germinal center-like areas with scattered apoptotic cells

hematopoietic system
• serum levels of IgGA in nave mice are lower than in controls
• similar defects are noted upon immunization with keyhole limpet hemocyanin (KLH)
• serum levels of IgG1 in nave mice are several log units lower than in controls
• these mice have severely impaired production of antigen-specific IgG1 after immunization with trinitrophenyl-conjugated chicken gamma-globulin (TNP-CGG)
• similar defects are noted upon immunization with KLH
• serum levels of IgG2a in nave mice are lower than in controls
• these mice have severely impaired production of antigen-specific IgG2a after immunization with TNP-CGG
• similar defects are noted upon immunization with KLH
• serum levels of IgG2b in nave mice are lower than in controls
• these mice have severely impaired production of antigen-specific IgG2b after immunization with TNP-CGG
• similar defects are noted upon immunization with KLH
• serum levels of IgG3 in nave mice are lower than in controls
• these mice have severely impaired production of antigen-specific IgG3 after immunization with TNP-CGG
• similar defects are noted upon immunization with KLH
• these mice have 10 to 20% of normal production levels of antigen-specific IgG2b after immunization with TNP-CGG
• similar defects are noted upon immunization with KLH




Genotype
MGI:5550267
cx12
Allelic
Composition
Il4tm1Cgn/Il4tm1Cgn
Ndfip1Gt(RRD002)Byg/Ndfip1Gt(RRD002)Byg
Genetic
Background
involves: 129P2/OlaHsd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il4tm1Cgn mutation (4 available); any Il4 mutation (46 available)
Ndfip1Gt(RRD002)Byg mutation (0 available); any Ndfip1 mutation (14 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• due to inflammatory disease

immune system
• increased percent in esophagus and lung mucosal tissues
• increased percent in esophagus and lung mucosal tissues
• increased percent in esophagus and lung mucosal tissues
• increased percent in esophagus and lung mucosal tissues
• compared with Il4tm1Cgn homozygotes
• at 12, but not 6, weeks

digestive/alimentary system

respiratory system

hematopoietic system
• increased percent in esophagus and lung mucosal tissues
• increased percent in esophagus and lung mucosal tissues
• increased percent in esophagus and lung mucosal tissues
• increased percent in esophagus and lung mucosal tissues




Genotype
MGI:4818945
cx13
Allelic
Composition
Il4tm1Cgn/Il4tm1Cgn
Tg(CD2-Stat6*V625A*T626A)78Mhk/0
Genetic
Background
involves: 129P2/OlaHsd * C3H * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il4tm1Cgn mutation (4 available); any Il4 mutation (46 available)
Tg(CD2-Stat6*V625A*T626A)78Mhk mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
integument
N
• mice do not exhibit skin inflammation unlike Tg(CD2-Stat6*V625A*T626A)78Mhk mice
• mice exhibit normal recovery from retinoic acid treatment




Genotype
MGI:3759409
cx14
Allelic
Composition
Il2tm1Hor/Il2tm1Hor
Il4tm1Cgn/Il4tm1Cgn
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il2tm1Hor mutation (5 available); any Il2 mutation (43 available)
Il4tm1Cgn mutation (4 available); any Il4 mutation (46 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cellular
• B cells from lymph nodes have a larger size, and incorporate more BrdU indicating a faster proliferation rate
• 2-10 fold higher using in vivo incorporation of BrdU, which indicates a faster proliferation rate

immune system
• B cells from lymph nodes have a larger size, and incorporate more BrdU indicating a faster proliferation rate
• 2-10 fold higher using in vivo incorporation of BrdU, which indicates a faster proliferation rate
• found in bone marrow
• found in bone marrow
• there are decreased levels of viral specific antibodies 9 days after infection with lymphocytic choriomeningitis virus (J:16662)
• serum levels of IgG and IgE are close to normal in uninfected mice, compared to the high levels of these immunoglobulins found in mice with just the mutant Il2 locus (J:16662)
• there is a nine fold reduction of target cell killing by primary T cells in a chromium release assay
• there is no target cell killing by previously stimulated T cells in a chromium release assay
• footpad swelling is strongly reduced 6-10 days after infection with lymphocytic choriomeningitis virus
• despite reduced cytotoxic T cell activity, mice still eliminate lymphocytic choriomeningitis virus within nine days of infection

hematopoietic system
• B cells from lymph nodes have a larger size, and incorporate more BrdU indicating a faster proliferation rate
• 2-10 fold higher using in vivo incorporation of BrdU, which indicates a faster proliferation rate
• found in bone marrow
• found in bone marrow
• there are decreased levels of viral specific antibodies 9 days after infection with lymphocytic choriomeningitis virus (J:16662)
• serum levels of IgG and IgE are close to normal in uninfected mice, compared to the high levels of these immunoglobulins found in mice with just the mutant Il2 locus (J:16662)
• there is a nine fold reduction of target cell killing by primary T cells in a chromium release assay
• there is no target cell killing by previously stimulated T cells in a chromium release assay
• footpad swelling is strongly reduced 6-10 days after infection with lymphocytic choriomeningitis virus




Genotype
MGI:3851988
cx15
Allelic
Composition
Il10tm1Cgn/Il10tm1Cgn
Il4tm1Cgn/Il4tm1Cgn
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il10tm1Cgn mutation (15 available); any Il10 mutation (45 available)
Il4tm1Cgn mutation (4 available); any Il4 mutation (46 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• mice exhibit enhanced Th1 responses after infection with S. mansoni eggs compared to controls
• there is a 75-fold increase in IFN-gamma mRNA in the lungs after infection with S. mansoni eggs

hematopoietic system
• mice exhibit enhanced Th1 responses after infection with S. mansoni eggs compared to controls




Genotype
MGI:4839051
cx16
Allelic
Composition
Faslpr/Faslpr
Il4tm1Cgn/Il4tm1Cgn
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6J * MRL/Mp
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Faslpr mutation (39 available); any Fas mutation (82 available)
Il4tm1Cgn mutation (4 available); any Il4 mutation (46 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• lympadenopathy (based on spleen weight and cellularity) is reduced compared to mice homozygous for Faslpr and wild-type for Il4
• relative to wild-type controls but decreased relative to mice homozygous for Faslpr and wild-type for Il4
• relative to wild-type controls but decreased relative to mice homozygous for Faslpr and wild-type for Il4
• at 7-8 months of age relative to mice homozygous for Faslpr and wild-type for Il4
• at 3 and 7-8 months of age relative to mice homozygous for Faslpr and wild-type for Il4
• at 3 and 7-8 months of age relative to mice homozygous for Faslpr and wild-type for Il4
• at 7-8 months of age relative to mice homozygous for Faslpr and wild-type for Il4
• lympadenopathy (based on lymph node weight and cellularity) is reduced compared to mice homozygous for Faslpr and wild-type for Il4
• while mice develop the typical autoimmune lesions end organ disease is decreased compared to mice homozygous for Faslpr and wild-type for Ifng
• incidence of end organ disease is increased compared to wild-type controls
• decrease in the percentage of FANA positive sera compared to controls at 3 months of age
• however, no significant differences in anti-dsDNA or anti-snRNP autoantibody levels are detected

homeostasis/metabolism
• levels are lower compared to mice homozygous for Faslpr and wild-type for Il4

hematopoietic system
• lympadenopathy (based on spleen weight and cellularity) is reduced compared to mice homozygous for Faslpr and wild-type for Il4
• relative to wild-type controls but decreased relative to mice homozygous for Faslpr and wild-type for Il4
• relative to wild-type controls but decreased relative to mice homozygous for Faslpr and wild-type for Il4
• at 7-8 months of age relative to mice homozygous for Faslpr and wild-type for Il4
• at 3 and 7-8 months of age relative to mice homozygous for Faslpr and wild-type for Il4
• at 3 and 7-8 months of age relative to mice homozygous for Faslpr and wild-type for Il4
• at 7-8 months of age relative to mice homozygous for Faslpr and wild-type for Il4

growth/size/body
• relative to wild-type controls but decreased relative to mice homozygous for Faslpr and wild-type for Il4
• relative to wild-type controls but decreased relative to mice homozygous for Faslpr and wild-type for Il4




Genotype
MGI:3799736
cx17
Allelic
Composition
Faslpr/Faslpr
Il4tm1Cgn/Il4tm1Cgn
Genetic
Background
MRL.Cg-Il4tm1Cgn Faslpr
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Faslpr mutation (39 available); any Fas mutation (82 available)
Il4tm1Cgn mutation (4 available); any Il4 mutation (46 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• dacryoadenitis, characterized by multiple foci of mononuclear inflammatory cells
• predominant cell type in infiltrate at various ages is CD4+ T cells (66%); CD8+ T cells make up 16% of infiltrate
• B cells are somewhat less abundant in infiltrates (18%) than in double mutants
• less severe than MRL/MpJ-Faslpr mice at 3 and 5 months

renal/urinary system
• less severe than MRL/MpJ-Faslpr mice at 3 and 5 months

vision/eye
• dacryoadenitis, characterized by multiple foci of mononuclear inflammatory cells
• predominant cell type in infiltrate at various ages is CD4+ T cells (66%); CD8+ T cells make up 16% of infiltrate
• B cells are somewhat less abundant in infiltrates (18%) than in double mutants

endocrine/exocrine glands
• dacryoadenitis, characterized by multiple foci of mononuclear inflammatory cells
• predominant cell type in infiltrate at various ages is CD4+ T cells (66%); CD8+ T cells make up 16% of infiltrate
• B cells are somewhat less abundant in infiltrates (18%) than in double mutants




Genotype
MGI:3625063
cx18
Allelic
Composition
Il4tm1Cgn/Il4tm1Cgn
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
Genetic
Background
NOD.Cg-Il4tm1Cgn Tg(TcraBDC2.5,TcrbBDC2.5)1Doi
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il4tm1Cgn mutation (4 available); any Il4 mutation (46 available)
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi mutation (3 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• equal degrees of insulitis are detected at 5 weeks in transgenic IL4-deficient NOD mice and control transgenic NOD mice

immune system
• equal degrees of insulitis are detected at 5 weeks in transgenic IL4-deficient NOD mice and control transgenic NOD mice
• Il4-deficient transgenic NOD mice do not show early or frequent diabetes compared to control transgenic NOD mice

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
type 1 diabetes mellitus DOID:9744 OMIM:222100
J:85924





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory